Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Michael Carulli Insider Profile
4 Followers
Michael Carulli, CFO at PMV Pharmaceuticals, holds 88.39K shares in PMV Pharmaceuticals (Ticker: PMVP). Most recently, Michael Carulli Sold $2,891 shares of PMV Pharmaceuticals on Sep 12, 2024 for an estimated value of 4.34K.
Michael Carulli has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Michael Carulli's holdings
Insider Roles
CFO
Roles that Michael Carulli holds in companies
Most Profitable Insider Trade
The most profitable trade made by Michael Carulli
Michael Carulli's Trading History
List of latest transactions for each holding click on a transaction to see Michael Carulli's performance on stock
You May Also Like
Michael Carulli insider profile FAQ
What is the percentage of profitable transactions made by Michael Carulli?
The percentage of profitable transactions made by Michael Carulli is ―.
What is the average return per transaction made by Michael Carulli?
The average return per transaction made by Michael Carulli is ―.
What stocks does Michael Carulli hold?
Michael Carulli holds: PMVP stocks.
What was Michael Carulli’s latest transaction?
Michael Carulli latest transaction was an Informative Sell of $4.34K.
What was Michael Carulli's most profitable transaction?
Michael Carulli’s most profitable transaction was an Informative Sell of PMVP stock on September 12, 2024. The return on the trade was -1.30%.
What is Michael Carulli's role in PMV Pharmaceuticals?
Michael Carulli's role in PMV Pharmaceuticals is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.